| |
7:30 – 8:20 AM Registration, Coffee, Exhibits |
| |
|
| |
|
| |
|
|
| 7:55 – 8:25 AM |
WHEN TO REFER FOR CRT OR VAD THERAPY: A CASE BASED APPROACH
Opening Breakout Session: Sponsored by Medtronic |
|
|
James Daubert, MD |
|
| |
|
 |
Joseph Rogers, MD |
|
| |
|
|
|
|
| |
|
| |
|
|
| 8:30 – 9:10 AM |
AM OPENING KEYNOTE ADVANCES IN HEART FAILURE:
Cardiac and Renal Effects of SGLT2 Inhibitors in Diabetes |
|
|
Eugene Braunwald, MD |
|
| |
|
|
|
|
AM OPENING KEYNOTE ADVANCES IN HEART FAILURE:
|
|
Session Moderator: Michael Bristow, MD, PhD
Panel Moderator: Mona Fiuzat, PharmD |
|
|
|
| 8:30 – 9:10 AM |
Current Management Strategies in HFpEF: The New Worldwide Epidemic
|
|
|
Orly Vardeny, PharmD |
|
| |
|
|
| 9:25 – 9:35 AM |
Should Race and Gender Affect Drug Therapy Decisions?
|
|
|
Clyde Yancy, MD |
|
| |
|
|
| 9:35 – 9:45 AM |
Beyond Diuretics – Anything Else for Symptom Relief?
|
|
|
G. Michael Felker, MD |
|
| |
|
|
| 9:45 – 9:55 AM |
Managing Hyperkalemia in Heart Failure Patients
|
|
|
Lauren Cooper, MD |
|
| |
|
|
| 9:55 – 10:05 AM |
Novel Therapies for Diabetes and Heart Failure
|
|
|
Javed Butler, MD |
|
| |
|
|
| 10:05 – 10:15 AM |
Treating Pulmonary Hypertension and RV Failure
|
|
|
Mitchell Psotka, MD, PhD |
|
| |
|
|
|
|
|
| 10:15 – 10:35 AM |
Clinical Cases and Panel Discussion (Moderator: Mona Fiuzat, PharmD)
|
|
|
Orly Vardeny, PharmD – Clinical Case #1 |
|
|
Mitchell Psotka, MD, PhD – Clinical Case #2 |
|
| |
Clyde Yancy, MD |
|
| |
G. Michael Felker, MD |
|
| |
Lauren Cooper, MD |
|
| |
Javed Butler, MD |
|
| |
Patient Representative |
|
|
| |
|
| |
10:35 - 11:15 AM Exhibit and Networking Break, Posters |
| |
|
| |
|
| |
|
|
| 10:45 – 11:15 AM |
UNDERSTANDING MITRAL REGURGITATION IN HEART FAILURE: A CASE BASED APPROACH
Morning Breakout Session: Sponsored by Abbott |
|
|
JoAnn Lindenfeld, MD |
|
| |
|
|
| |
William Abraham, MD |
|
|
|
| |
|
|
| |
DEVICES: CUTTING EDGE DEVICE THERAPY FOR HEART FAILURE
|
|
| |
Session Moderator: Alan Miller, MD
Panel Moderator: Peter Carson, MD |
|
| |
|
|
|
|
|
|
| |
|
| 11:20 – 11:30 AM |
Sensor Strategies for Heart Failure – Apple, Oranges and Bananas
|
|
|
David Whellan, MD |
|
| |
|
|
| 11:30 – 11:40 AM |
Ablation, ICD’s and CRT for Heart Failure
|
|
|
James Daubert, MD |
|
| |
|
|
| 11:40 – 11:50 AM |
Sleep Apnea – To Treat or Not to Treat?
|
|
|
Christopher O’Connor, MD |
|
| |
|
|
| 11:50 AM – 12:00 PM |
Novel Device Therapies for HF
|
|
|
William Abraham, MD |
|
| |
|
|
| 12:00 – 12:10 PM |
Treating Mitral Regurgitation in HF
|
|
|
JoAnn Lindenfeld, MD |
|
| |
|
|
| 12:10 – 12:20 PM |
The Intersection of A. Fib and HF
|
|
|
Michael Bristow, MD, PhD |
|
| |
|
|
| 12:20 – 12:30 PM |
Patient Decisions about Device Therapy
|
|
|
Mary Walsh, MD |
|
| |
|
|
| 12:30 – 12:50 PM |
Clinical Cases and Panel Discussion (Moderator: Peter Carson, MD)
|
|
|
Mary Walsh, MD – Clinical Case #1 |
|
| |
Alan Miller, MD – Clinical Case #2 |
|
| |
David Whellan, MD |
|
| |
Michael Bristow, MD, PhD |
|
| |
JoAnn Lindenfeld, MD |
|
| |
Christopher O’Connor, MD |
|
| |
William Abraham, MD |
|
| |
James Daubert, MD |
|
|
| |
|
| |
12:50 – 1:25 PM Lunch, Exhibits and Networking |
| |
|
| |
|
| |
|
|
| 1:05 – 1:20 PM |
Poster Session |
|
| |
Moderators / Judges: Lauren Cooper, MD; Mitch Psotka, MD; Palak Shah, MD; Chris deFilippi, MD |
|
|
|
| |
|
|
| |
|
|
| 1:30 – 2:15 PM |
LUNCH KEYNOTE SESSION 1:30 – 1:50 PM: THE FUTURE OF HEALTHCARE AND CV MEDICINE IN AMERICA
|
|
|
Robert Califf, MD |
|
| |
1:50 – 2:15 PM: PANEL
|
|
| |
Moderator: Christopher M. O’Connor
Panelists: Robert Califf, MD;
Alan Speir, MD; Harlan Krumholz, MD
|
|
| |
|
|
|
| |
|
|
DEBATES AND HEALTH POLICY
|
|
Session Moderator: Tariq Ahmad, MD
Panel Moderator: Christopher O’Connor, MD |
|
|
|
|
|
|
|
| |
|
| |
DEBATE 1: CARDIO-ONCOLOGY: DOES LVEF MATTER?
|
|
| |
|
|
| 2:20 – 2:30 PM |
LVEF Changes Should be Managed
|
|
|
Ana Barac, MD |
|
| |
|
|
| 2:30 – 2:40 PM |
No Clear Evidence
|
|
|
Marvin Konstam, MD |
|
| |
|
|
| |
DEBATE 2: SHOULD WE USE BIOMARKERS TO GUIDE THERAPY?
|
|
| |
|
|
| 2:40 – 2:50 PM |
Use Biomarkers to Guide Therapy
|
|
|
James Januzzi, MD |
|
| |
|
|
| 2:50 – 3:00 PM |
Guideline Directed, not Biomarker Guided
|
|
|
Clyde Yancy, MD |
|
| |
|
|
| |
DEBATE 3: HOW TO TREAT WOMEN: FROM THE EXPERTS
|
|
| |
|
|
| 3:00 – 3:10 PM |
Expert #1
|
|
| |
Roxana Mehran, MD |
|
| |
|
|
| 3:10 – 3:20 PM |
Expert #2
|
|
|
Hector Ventura, MD 3: |
|
| |
|
|
| 3:20 – 3:40 PM |
Panel Discussion (Moderator: Christopher O’Connor, MD)
|
|
| |
Roxana Mehran, MD |
|
| |
Hector Ventura, MD |
|
| |
Ana Barac, MD |
|
| |
Marvin Konstam, MD |
|
| |
James Januzzi, MD |
|
| |
Clyde Yancy, MD |
|
| |
|
|
|
|
3:40 – 3:55 PM Exhibits and Networking Coffee Break |
| |
|
| |
|
|
|
| |
CUTTING EDGE CONCEPTS IN ADVANCED HEART FAILURE
|
|
Session Moderator: Gurusher Panjrath, MD
Panel Moderator: Shashank Desai, MD |
|
|
|
|
|
|
|
| |
|
| The University of Massachusetts Medical School designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. |
|
| |
|
|
| 3:55 – 4:05 PM |
Palliative Care in End Stage Heart Failure: Symptom Management
|
|
|
Joseph Rogers, MD |
|
| |
|
|
| 4:05 – 4:15 PM |
The New Allocation System: Who is Appropriate for Heart Transplant or Mechanical Support?
|
|
|
Shashank Desai, MD |
|
| |
|
|
| 4:15 – 4:25 PM |
Novel Mechanical Support Devices in 2018
|
|
|
Ramesh Singh, MD |
|
| |
|
|
| 4:25 – 4:35 PM |
Medical Management of LVAD patients for the Non-LVAD Specialist
|
|
|
Tariq Ahmad, MD |
|
| |
|
|
| 4:35 – 4:45 PM |
Cutting Edge Concepts in Surgical Options
|
|
|
Linda Bogar, MD |
|
| |
|
|
| 4:45 – 4:55 PM |
Improving Outcomes in Cardiogenic Shock
|
|
|
Behnam Tehrani, MD |
|
| |
|
|
| 4:55 – 5:15 PM |
Clinical Cases and Panel Discussion (Moderator: Shashank Desai, MD)
|
|
|
Palak Shah, MD – Clinical Case #1 |
|
|
Gurusher Panjrath, MD – Clinical Case #2 |
|
| |
Joseph Rogers, MD |
|
| |
Christopher May, MD |
|
| |
Linda Bogar, MD |
|
| |
Ramesh Singh, MD |
|
| |
|
|
| |
|
|
|
